CureVac N.V. (ETR:5CV)
Germany
· Delayed Price · Currency is EUR 2.616
+0.040 (1.55%)
Apr 1, 2025, 10:40 AM CET
CureVac Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Revenue | 65.86 | 53.76 | 67.42 | 102.99 | 48.87 | 17.42 | Upgrade
|
Revenue Growth (YoY) | 75.11% | -20.26% | -34.54% | 110.74% | 180.61% | 35.31% | Upgrade
|
Cost of Revenue | 152.13 | 116.21 | 158.97 | 215.27 | 14.17 | 27.98 | Upgrade
|
Gross Profit | -86.28 | -62.45 | -91.55 | -112.28 | 34.7 | -10.57 | Upgrade
|
Selling, General & Admin | 84.98 | 95.74 | 107.07 | 102.26 | 54.29 | 50.72 | Upgrade
|
Research & Development | 116.28 | 115.72 | 62.55 | 815.91 | 113.81 | 43.24 | Upgrade
|
Other Operating Expenses | -1.82 | -2.17 | -34.83 | -0.1 | 0.15 | 0.35 | Upgrade
|
Operating Expenses | 199.37 | 209.29 | 134.8 | 918.07 | 168.25 | 94.32 | Upgrade
|
Operating Income | -285.64 | -271.74 | -226.34 | -1,030 | -133.55 | -104.88 | Upgrade
|
Interest Expense | - | - | -2.3 | -6.79 | -22.1 | -1.46 | Upgrade
|
Interest & Investment Income | 13.87 | 15.41 | 1.73 | 0.08 | 2.07 | 0.83 | Upgrade
|
Currency Exchange Gain (Loss) | -1.21 | -1.21 | 0.87 | 6.15 | - | - | Upgrade
|
Other Non Operating Income (Expenses) | 0.04 | 0.04 | -0 | 0.32 | - | - | Upgrade
|
EBT Excluding Unusual Items | -272.95 | -257.51 | -226.04 | -1,031 | -153.58 | -105.51 | Upgrade
|
Gain (Loss) on Sale of Assets | 1.16 | 1.2 | 0.79 | - | - | - | Upgrade
|
Asset Writedown | -11.33 | -8.09 | -24.95 | -22.81 | - | - | Upgrade
|
Other Unusual Items | 5.97 | 3.57 | 0.44 | 640.9 | 23.74 | 5.39 | Upgrade
|
Pretax Income | -276.29 | -259.97 | -249.16 | -412.5 | -129.85 | -100.13 | Upgrade
|
Income Tax Expense | 2.14 | 0.2 | -0.13 | -0.78 | -0.73 | -0.25 | Upgrade
|
Net Income | -278.43 | -260.17 | -249.03 | -411.72 | -129.12 | -99.87 | Upgrade
|
Net Income to Common | -278.43 | -260.17 | -249.03 | -411.72 | -129.12 | -99.87 | Upgrade
|
Shares Outstanding (Basic) | 224 | 221 | 189 | 186 | 132 | 97 | Upgrade
|
Shares Outstanding (Diluted) | 224 | 221 | 189 | 186 | 132 | 97 | Upgrade
|
Shares Change (YoY) | 9.65% | 16.80% | 1.65% | 40.71% | 36.72% | - | Upgrade
|
EPS (Basic) | -1.24 | -1.18 | -1.32 | -2.21 | -0.98 | -1.03 | Upgrade
|
EPS (Diluted) | -1.24 | -1.18 | -1.32 | -2.21 | -0.98 | -1.03 | Upgrade
|
Free Cash Flow | -323.44 | -320.21 | -374.2 | -857.35 | 486.07 | -98.14 | Upgrade
|
Free Cash Flow Per Share | -1.44 | -1.45 | -1.98 | -4.61 | 3.68 | -1.01 | Upgrade
|
Gross Margin | -131.00% | -116.17% | -135.79% | -109.02% | 71.00% | -60.67% | Upgrade
|
Operating Margin | -433.71% | -505.49% | -335.72% | -1000.44% | -273.27% | -602.22% | Upgrade
|
Profit Margin | -422.77% | -483.96% | -369.37% | -399.76% | -264.21% | -573.45% | Upgrade
|
Free Cash Flow Margin | -491.11% | -595.64% | -555.03% | -832.46% | 994.61% | -563.48% | Upgrade
|
EBITDA | -270.34 | -254.95 | -209.39 | -1,020 | -123.1 | -97.72 | Upgrade
|
EBITDA Margin | - | - | - | - | -251.88% | - | Upgrade
|
D&A For EBITDA | 15.3 | 16.79 | 16.96 | 10.31 | 10.46 | 7.16 | Upgrade
|
EBIT | -285.64 | -271.74 | -226.34 | -1,030 | -133.55 | -104.88 | Upgrade
|
EBIT Margin | - | - | - | - | -273.27% | - | Upgrade
|
Updated Aug 15, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.